Logo-ps
Pharm Sci. 2023;29(1): 1-19. doi: 10.34172/PS.2022.23

Review Article

Modulation of Nrf2 by Activation of Estrogen Receptor β as a Therapeutic Strategy to Prevent Cancer Development and Overcome Inflammation-Related Drug Resistance in Breast Cancer

Emdormi Rymbai 1 ORCID, Deepa Sugumar 1, Jubie Selvaraj 2, Ram Kothandam 3, Divakar Selvaraj 1 * ORCID

Cited by CrossRef: 0


1- Ahn W, Ji J, Choi S, Han S, Park J, Park S, Cheon J, Kim T, Park J. Clinical Usefulness of Computed Tomography Enterography as a Diagnostic Modality for Isolated Terminal Ileitis. Gut and Liver. 2026;20(6):1017 [Crossref]
2- Rymbai E, Roy D. Neuroimmune Regulation of NLRP3 Signalling in Parkinson’s Disease. Mol Neurobiol. 2026;63(1) [Crossref]
3- Choi Y, Kim N, Song C, Oh H. Sex Hormone Receptor Profiling Reveals an Association between Estrogen Receptor β-NRF2 Signaling and Improved Outcomes in Colorectal Cancer Patients. Gut and Liver. 2026;20(6):1026 [Crossref]
4- Kopacz A, Tomaszewska Z, Piechota-Polanczyk A. Estrogen receptors and the NRF2 pathway: bridging hormonal regulation and stress response in the gut. Front Endocrinol. 2026;17 [Crossref]

   Indexing & Abstracting: